Rephonic
Artwork for OncLive® On Air

OncLive® On Air

OncLive® On Air
Triple Negative Breast Cancer
Non-Small Cell Lung Cancer
Clinical Trials
Immunotherapy
Breast Cancer
Small Cell Lung Cancer
Multiple Myeloma
Antibody Drug Conjugates
Bladder Cancer
FDA Approval
Chronic Lymphocytic Leukemia
Oncology
Pembrolizumab
Chemotherapy
Prostate Cancer
Metastatic Breast Cancer
Colorectal Cancer
BTK Inhibitors
Chronic Myeloid Leukemia
Hr-Positive Her2-Negative Metastatic Breast Cancer

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

PublishesDailyEpisodes500Founded8 years ago
Number of ListenersCategories
Health & FitnessScience

Listen to this Podcast

Artwork for OncLive® On Air

Latest Episodes

In today’s episode, we welcomed Everett Meyer, MD, PhD, an associate professor of medicine (blood & marrow transplantation), an associate professor of pediatrics (stem cell transplantation), and an associate professor of surgery (abdominal transplant... more

In today’s episode, we spoke with Paolo Tarantino, MD, PhD. Dr Tarantino is a breast medical oncologist and advanced fellow at Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts.

In our exclusive interview, Dr Tarantino... more

In today’s episode, we spoke with Sara M. Tolaney, MD, MPH, about the FDA approval of sacituzumab govitecan plus pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the first-line treatment of adult patients ... more

In today’s episode, we spoke with Jorge E. Cortes, MD, and Elias Jabbour, MD. Dr Cortes is the chief of Hematology in the Division of Hematology and Oncology and the associate director for Translation at the UAB O’Neal Cancer Center in Birmingham, Al... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Neil D. Gross
MD, FACS; Medical Director of Perioperative Surgical Services, MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: S17 Ep56: Navigating Systemic Therapy Selection and Sequencing in Advanced CSCC: With Neil D. Gross, MD, FACS
Justin Gainor
Physician discussing ROS-1/RET inhibitors data
Episode: S17 Ep54: Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology
Julia Rotow
Physician discussing emerging KRAS inhibitors and immunotherapies
Episode: S17 Ep54: Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology
Urs Weber
Physician discussing immunotherapies in NSCLC
Episode: S17 Ep54: Tumor Board: Optimizing NSCLC Care—Leveraging the Latest Evidence on Targeted Therapy and Immuno-Oncology
Kamel Abou Hussein
Episode: S17 Ep53: Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Seth Wander
Episode: S17 Ep53: Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Virginia Kaklamani
Episode: S17 Ep53: Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Javier Cortés
Episode: S17 Ep53: Oncology Town Hall: Updates From Chicago: Oral SERDs in HR+/HER2– Metastatic Breast Cancer—What the Latest Data Really Tell Us
Gerald Soff
Oncologist featured in interview
(not explicitly stated in transcript)
Episode: S17 Ep51: RECITE Findings Highlight the Potential of Romiplostim to Preserve Chemotherapy Delivery in GI Cancer: With Gerald Soff, MD

Hosts

Riley Kandel
Host of OncLive On Air
Aisling Wehner
Host of OncLive On Air

Reviews

4.5 out of 5 stars from 33 ratings
  • Best option for CME podcasts

    Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!

    Apple Podcasts
    5
    Dlshaka
    United Statesa year ago
  • My favorite podcast for oncology

    This podcast provides excellent information to anyone who works in the medical field on oncology.

    Apple Podcasts
    5
    Chiliman1986
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Highly relevant for CME and clinical practice updates.
Strong focus on trials and biomarkers; great for sponsor alignment with oncologic education.
Consistently practical and data-driven, though dense for casual listeners.
Clear, credible expert voices with in-depth clinical context.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

S17 Ep56: Navigating Systemic Therapy Selection and Sequencing in Advanced CSCC: With Neil D. Gross, MD, FACS
Q: What role do trials like NRG HN14 and ongoing neoadjuvant/adjuvant studies play in guiding treatment plans today and in the near term?
These trials provide critical data on neoadjuvant versus upfront surgery approaches, potential survival benefits, and safety profiles, guiding clinicians toward evidence-based sequencing strategies and expanding options beyond standard of care based on trial outcomes.
S17 Ep56: Navigating Systemic Therapy Selection and Sequencing in Advanced CSCC: With Neil D. Gross, MD, FACS
Q: How do you decide which CSCC patients are best suited for immunotherapy versus surgery-first approaches, especially in locally advanced or borderline resectable disease?
Decisions hinge on resectability status, potential functional impact, and likelihood of achieving durable control. In borderline cases, upfront systemic therapy can preserve function and potentially render tumors resectable, with considerations for neoadjuvant windows and monitoring for adverse events.
S17 Ep56: Navigating Systemic Therapy Selection and Sequencing in Advanced CSCC: With Neil D. Gross, MD, FACS
Q: In what ways do you frame the key biological and clinical distinctions between CSCC and BCC in terms of metastatic potential, immune responsiveness, and implications for systemic therapy selection?
CSCC carries a higher metastatic risk and responds robustly to anti-PD-1 therapy, making systemic immunotherapy a central option for unresectable or metastatic disease, while BCC tends to be more indolent and less responsive to systemic therapies, making surgery and hedgehog inhibitors more common first-line approaches for advanced cases.
S17 Ep39: Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD
Q: So starting off, in patients with platinum-resistant ovarian cancer, how do you currently approach treatment selection and sequencing? What clinical or molecular features most strongly influence your decision-making?
The approach centers on prioritizing clinical trials as tomorrow's therapies today, using biomarker-driven decisions (like folate receptor alpha and HER2) and weighing practical factors such as infusion logistics, patient travel, and quality of life to guide sequencing.
S17 Ep44: SERENA-6 Splits the Breast Cancer Field on Switching Therapy Before Radiographic Progression: With Sara Nunnery, MD, MSCI; and Megan Kruse, MD
Q: What was the current standard for how we're testing for ESR1 mutations?
Tests are increasingly done through liquid biopsy to capture tumor heterogeneity across metastatic sites, with testing occurring over time rather than just at initial diagnosis.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A concise, clinician-focused show featuring in-depth conversations with academic oncologists and researchers about cutting-edge cancer care, trial results, and evolving treatment paradigms across thoracic, breast, GI, and gynecologic malignancies. Episodes emphasize biomarker-driven strategies, targeted therapies, and practical workflows for multidisciplinary teams, often discussing real-world implementation, patient impact, and access considerations. Noteworthy strengths include a strong emphasis on data interpretation, up-to-date trial context, and insights from leading cancer centers, making it especially valuable for oncology professionals seeking continuing education, clinical guidance, and context for emerging therapies. Potential lis... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Neil D. Gross
2. Justin Gainor
3. Julia Rotow
4. Urs Weber
5. Kamel Abou Hussein
6. Seth Wander
7. Virginia Kaklamani
8. Javier Cortés

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days